middle.news

Telix Surpasses FY24 Revenue Targets with US$142M Q4 Surge

7:03pm on Monday 2nd of June, 2025 AEST Biotechnology
Read Story

Telix Surpasses FY24 Revenue Targets with US$142M Q4 Surge

7:03pm on Monday 2nd of June, 2025 AEST
Key Points
  • Q4 2024 revenue hits US$142 million, up 46% year-on-year
  • Full-year 2024 revenue reaches US$517 million, surpassing guidance
  • Progress on multiple therapeutic candidates including TLX591 and TLX250
  • Acquisition of FAP-targeting assets and antibody platform expands pipeline
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about TLX
OPEN ARTICLE